Paper38425919
Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy.
Zhou P and 10 others. JACS Au, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy. Papers, record 38425919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38425919
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31139713 | Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression. | ACS Cent Sci | 2019 | https://conductscience.org/library/papers/31139713 | PubMed |
| 2 | 30814649 | Identification of bioactive metabolites using activity metabolomics. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30814649 | PubMed |
| 3 | 34646386 | Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer. | Theranostics | 2021 | https://conductscience.org/library/papers/34646386 | PubMed |
| 4 | 33652221 | Breast cancer proliferation and deterioration-associated metabolic heterogeneity changes induced by exposure of bisphenol S, a widespread replacement of bisphenol A. | J Hazard Mater | 2021 | https://conductscience.org/library/papers/33652221 | PubMed |
| 5 | 24985940 | Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. | Trends Cell Biol | 2014 | https://conductscience.org/library/papers/24985940 | PubMed |
| 6 | 17035995 | Phosphoinositides in cell regulation and membrane dynamics. | Nature | 2006 | https://conductscience.org/library/papers/17035995 | PubMed |
| 7 | 21062159 | Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. | Future Oncol | 2010 | https://conductscience.org/library/papers/21062159 | PubMed |
| 8 | 33188273 | Crosstalk between mechanotransduction and metabolism. | Nat Rev Mol Cell Biol | 2021 | https://conductscience.org/library/papers/33188273 | PubMed |
| 9 | 19669618 | The glycerophosphoinositols: cellular metabolism and biological functions. | Cell Mol Life Sci | 2009 | https://conductscience.org/library/papers/19669618 | PubMed |
| 10 | 27821323 | Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer. | Eur J Cancer | 2016 | https://conductscience.org/library/papers/27821323 | PubMed |
| 11 | 31548545 | Breast cancer. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31548545 | PubMed |
| 12 | 29731990 | Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. | Oncotarget | 2018 | https://conductscience.org/library/papers/29731990 | PubMed |
| 13 | 34901900 | Mass spectrometry imaging-based multi-modal technique: Next-generation of biochemical analysis strategy. | Innovation (Camb) | 2021 | https://conductscience.org/library/papers/34901900 | PubMed |
| 14 | 36633187 | Divide and Conquer: A Flexible Deep Learning Strategy for Exploring Metabolic Heterogeneity from Mass Spectrometry Imaging Data. | Anal Chem | 2023 | https://conductscience.org/library/papers/36633187 | PubMed |
| 15 | 35686331 | Advances in high-resolution mass spectrometry techniques for analysis of high mass-to-charge ions. | Mass Spectrom Rev | 2023 | https://conductscience.org/library/papers/35686331 | PubMed |
| 16 | 37164974 | Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37164974 | PubMed |
| 17 | 19279183 | Ceramide synthases and ceramide levels are increased in breast cancer tissue. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19279183 | PubMed |
| 18 | 33235291 | Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo. | Oncogene | 2021 | https://conductscience.org/library/papers/33235291 | PubMed |
| 19 | 20876798 | De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. | Cancer Res | 2010 | https://conductscience.org/library/papers/20876798 | PubMed |
| 20 | 23235911 | Ceramide-orchestrated signalling in cancer cells. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23235911 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41826648 | Metabolic networks in the tumor microenvironment: roles of amino acid and lipid metabolism pathways in cancer progression and therapy. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/41826648 | PubMed |
| 40723225 | Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723225 | PubMed |
| 40197022 | MSIght: A Modular Platform for Improved Confidence in Global, Untargeted Mass Spectrometry Imaging Annotation. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40197022 | PubMed |
| 39484162 | Cancer metabolic reprogramming and precision medicine-current perspective. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39484162 | PubMed |
| 39437423 | Recent Developments in Single-Cell Metabolomics by Mass Spectrometry─A Perspective. | J Proteome Res | 2025 | https://conductscience.org/library/papers/39437423 | PubMed |
| 39285904 | Microplastome visualizations: From spatiotemporal distribution to risk assessment. | Innovation (Camb) | 2024 | https://conductscience.org/library/papers/39285904 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NBEAL2 | 23218 | PubTator's text mining | https://conductscience.org/library/genes/23218 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38425919
GET https://conductscience.org/api/papers/v1/38425919/references?page=2